Ligand validation:3AEF

EPH: L-ALPHA-PHOSPHATIDYL-BETA-OLEOYL-GAMMA-PALMITOYL-PHOSPHATIDYLETHANOLAMINE

EPH is a Ligand Of Interest in 3AEF designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3AEF_EPH_D_1306	17%	31%	0.264	0.863	1.52	1.33	6	4	0	1	90%	0.898
1ZOY_EPH_D_1306	15%	14%	0.276	0.859	1.84	2.23	9	5	3	0	90%	0.898
3ABV_EPH_D_1306	7%	32%	0.395	0.878	1.6	1.2	7	2	0	0	90%	0.898
3AE2_EPH_D_1306	3%	32%	0.37	0.748	1.53	1.31	6	3	0	1	90%	0.898
3AE3_EPH_D_1306	2%	30%	0.594	0.896	1.73	1.19	8	3	0	1	90%	0.898
3AE1_EPH_D_1306	2%	33%	0.552	0.826	1.56	1.22	7	2	0	1	90%	0.898
4ONI_EPH_A_601	63%	46%	0.144	0.939	1.01	1.08	2	3	2	0	100%	1
5Z9O_EPH_B_402	61%	43%	0.167	0.965	1.05	1.2	3	4	9	0	96%	0.9592
4DOR_EPH_B_601	49%	46%	0.158	0.912	0.98	1.12	2	5	9	0	96%	0.9592
4YSX_EPH_D_201	34%	42%	0.182	0.886	1.13	1.18	2	4	2	0	90%	0.898
3VRB_EPH_D_201	34%	13%	0.227	0.932	1.83	2.28	9	5	5	0	90%	0.898

RCSB PDB Core Operations are funded by the National Science Foundation (DBI-1832184), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.